CMR Surgical launches ultrasonic advance for robotics surgery
The Ultrasonic Dissector is the first instrument in the advanced energy instrument range to be introduced by CMR.
It was developed to deliver ultrasonic energy via a torsional design, and can seal vessels up to 5 mm in diameter, with a mean burst pressure of 908 mmHg,ii – 7.5x that of normal systolic blood pressure.
The Ultrasonic Dissector promotes haemostatic coagulation and simultaneous cutting with multiple, surgeon-selectable modes to suit each procedural need, supporting surgeons through more complex surgical procedures.
The introduction of the Ultrasonic Dissector to the Versius instrument suite completes a series of product launches made as part of Versius Plus, which is designed to facilitate advanced surgical procedures across all specialities. It includes an expanded instrument portfolio, improved console, advanced digital insights and vLimeLite our fluorescent imaging system for the visualisation of ICG.
Michelle Paknad, President of Global Marketing & US Market Entry at CMR Surgical said: "We're excited to be bringing advanced energy, in the form of the Ultrasonic Dissector, to the Versius Plus offering.
“We have listened to the needs of our clinical partners and I’m delighted that we have been able to develop a practical tool that provides the ability to cut and coagulate tissue through ultrasonic energy, enabling them to perform more complex surgical procedures with Versius and bring the benefits of robotic-assisted minimal access surgery to more patients.”
Mark Slack, Chief Medical Officer and Co-founder at CMR Surgical added: “The introduction of the Ultrasonic Dissector is an important next step in our instrument portfolio. We’ve worked closely with our clinical partners to bring this proven ultrasonic instrument to Versius and are looking forward to seeing the positive impact it will have for surgeons using Versius.
“As a multifunctional instrument, Ultrasonic Dissector provides enhanced capability to Versius, allowing surgeons to seal blood vessels – supporting them to do more complex procedures with the system and thereby bring more robotic-assisted minimal access surgery to their patients.”
Versius has been used to perform over 27,000 surgical procedures globally, with over 130 different surgical procedures undertaken across seven surgical specialties.
The system is in routine use for both complex and high-volume low complexity procedures across urology, general surgery, gynaecology, colorectal surgery, and thoracic surgery, with the introduction of the Ultrasonic Dissector set to further support surgeons to perform complex surgical procedures robotically with Versius.
